Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
May 5, 2026
Reporting period
Not applicable
Filed with the SEC
May 7, 2026
OfficerGrant / award
Context
Classification
grant award
Code A — grant or award
Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0000310158-26-000119
Filed / recorded
May 7, 2026, 3:39 PM UTC
Added to OQRO
Oct 2, 2026, 3:52 AM UTC
Parser
form4-xml-v1
Data quality
Verified: identifiers matched exactly
Issuer
Merck & Co., Inc.
Issuer CIK
310158
Ticker
MRK
Reporting person
Dalton E. Iii Smart
Relationship
Officer
Officer title
SVP Fin. - Global Controller
Security
Restricted Stock Unit
Table
Derivative (Table II)
Transaction date
May 5, 2026
Transaction code
A
Shares / units
2,298
Price per share
$0.00
Acquired / disposed
Acquired (A)
Shares owned after
2,298
Ownership form
Direct
Amendment
No
Footnotes from the filing
Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/5/2027, 5/5/2028, and, 5/5/2029.